Liver Cancer

With earlier diagnosis, the prognosis of those with liver cancer is greatly improved. Our VeraMarker™ metabolite profiling test enables early, more accurate diagnosis.

Learn More »


Metabolite Profiling

The need for improved cancer diagnostics is compelling. Yet molecular diagnostics employing DNA, RNA, and proteins have not delivered as expected with actionable clinical tests.

Learn More »


Investor + Partner Ready

Matrix-Bio is seeking investors and strategic partners to validate our potentially clinically superior VeraMarker™ liver cancer diagnostics test.

Learn More »